FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its third quarter ended September 30, 2008. For the quarter ended September 30, 2008, NovaDel reported a net loss of $2.5 million, or $0.04 per share, compared to a net loss of $2.4 million, or $0.04 per share, for the quarter ended September 30, 2007. For the nine months ended September 30, 2008, NovaDel reported a net loss of $7.7 million, or $0.13 per share, as compared to a net loss of $13.2 million, or $0.22 per share for the nine months ended September 30, 2007.
